DARE DARE BIOSCIENCE INC Capital Structure Changes 8-K Filing 2025 - Nasdaq Compliance Extension On April 9, 2025, DARE Bioscience, Inc. received an extension until August 12, 2025, from Nasdaq to demonstrate compliance with listing rules regarding stockholders' equity of at least $2.5 million or a market value of $35 million, after being non-compliant since August 2024.Get access to all SEC 8-K filings of the DARE BIOSCIENCE INC